Cargando…
Targeting the RNA demethylase FTO for cancer therapy
N (6)-Methyladenosine (m(6)A) is the most prevalent internal modification on mRNA and represents a new layer of gene expression in eukaryotes. The field of m(6)A-encoded epitranscriptomics was rejuvenated with the discovery of fat mass and obesity-associated protein (FTO) as the first m(6)A demethyl...
Autores principales: | Zhou, Lin-Lin, Xu, Hongjiao, Huang, Yue, Yang, Cai-Guang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
RSC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496078/ https://www.ncbi.nlm.nih.gov/pubmed/34704042 http://dx.doi.org/10.1039/d1cb00075f |
Ejemplares similares
-
Discovery of novel mRNA demethylase FTO inhibitors against esophageal cancer
por: Qin, Bo, et al.
Publicado: (2022) -
Expression of Demethylase Genes, FTO and ALKBH1, Is Associated with Prognosis of Gastric Cancer
por: Li, Yue, et al.
Publicado: (2019) -
A fluorescent methylation-switchable probe for highly sensitive analysis of FTO N(6)-methyladenosine demethylase activity in cells
por: Cheong, Adeline, et al.
Publicado: (2018) -
Effect of Posttranslational Modifications on the Structure and Activity of FTO Demethylase
por: Marcinkowski, Michał, et al.
Publicado: (2021) -
Substrates of the m(6)A demethylase FTO: FTO-LINE1 RNA axis regulates chromatin state in mESCs
por: Sommerkamp, Pia
Publicado: (2022)